GlassScriptPhysician profile
Jihane Saade
NPI 1306591516
$9,144.56
in general payments reported to CMS, 2019-2025
62 companies · $2,413 in 2025
The $2,413 reported for 2025 was more than what 95% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.50 · 2022: $2,082 · 2023: $1,414 · 2024: $3,192 · 2025: $2,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,079 · Long Term Medical Supply Or Device Loan: $1,280 · Consulting Fee: $425 · Education: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,079.34 |
| Long Term Medical Supply Or Device Loan | $1,279.73 |
| Consulting Fee | $425.00 |
| Education | $234.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,959.61 | 2023-2025 | Piqray, Kisqali |
| Amgen INC. | $979.62 | 2022-2024 | Xgeva, Nplate, Vectibix |
| Abbvie INC. | $556.30 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $537.23 | 2022-2025 | Enhertu, Lynparza, Calquence |
| Becton, Dickinson and Company | $425.00 | 2024 | |
| Daiichi Sankyo INC. | $374.55 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Eisai INC. | $373.43 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $318.96 | 2024-2025 | Opdivo, Reblozyl |
| Janssen Biotech, INC. | $311.08 | 2022-2025 | Erleada, Darzalex, Akeega |
| Taiho Oncology, INC. | $258.53 | 2022-2025 | |
| Incyte Corporation | $234.37 | 2024-2025 | Jakafi |
| Stemline Therapeutics INC. | $191.30 | 2023-2025 | Orserdu |
| Takeda Pharmaceuticals U.S.A., INC. | $168.27 | 2023-2025 | Vpriv, Alunbrig, Ninlaro |
| Pharmacyclics LLC, An Abbvie Company | $161.35 | 2022-2023 | Imbruvica, Epkinly |
| Bayer Healthcare Pharmaceuticals INC. | $157.55 | 2021-2025 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $123.40 | 2024-2025 | Xpovio |
| Glaxosmithkline, LLC. | $118.61 | 2023-2025 | Ojjaara, Shingrix, Jemperli |
| Rigel Pharmaceuticals, INC. | $113.98 | 2022-2025 | Gavreto, Tavalisse, Rezlidhia |
| Genzyme Corporation | $102.59 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2023 | |
| Seagen INC. | $99.95 | 2022 | |
| Lilly USA, LLC | $85.51 | 2022-2024 | Verzenio, Jaypirca, Retevmo |
| Blueprint Medicines Corporation | $79.92 | 2023-2025 | Ayvakit |
| Pharmaessentia USA Corporation | $78.32 | 2024-2025 | Besremi |
| Genentech USA, INC. | $77.52 | 2023-2025 | Tecentriq, Alecensa, Polivy |
| Macrogenics, INC. | $70.83 | 2022-2023 | |
| Tersera Therapeutics LLC | $66.06 | 2023-2025 | Xermelo, Zoladex |
| Aveo Pharmaceuticals, INC. | $63.71 | 2022-2025 | Fotivda |
| Sobi, INC | $62.64 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.70 | 2021-2023 | Gilotrif |
| Coherus Oncology, INC. | $59.97 | 2022-2023 | |
| Astellas Pharma US INC | $59.28 | 2023-2024 | Xtandi |
| Pfizer INC. | $51.92 | 2022-2024 | |
| Ipsen Biopharmaceuticals, INC | $48.88 | 2022-2023 | Onivyde, Somatuline Depot |
| Spectrum Pharmaceuticals INC. | $40.97 | 2024-2025 | Rolvedon |
| Adc Therapeutics America, INC. | $40.89 | 2025 | |
| Dendreon Pharmaceuticals LLC | $38.62 | 2025 | Provenge |
| Pharmacosmos Therapeutics INC. | $32.93 | 2022 | |
| Iovance Biotherapeutics, INC. | $32.25 | 2025 | Amtagvi |
| Kyowa Kirin, INC. | $31.44 | 2023 | Poteligeo |
| Progenics Pharmaceuticals, INC. | $29.25 | 2025 | |
| Octapharma USA, INC. | $28.94 | 2022-2024 | Octagam Immune Globulin (Human) |
| Recordati_rare_diseases_inc. | $22.24 | 2025 | Panhematin |
| Novocure INC. | $20.17 | 2025 | Optune Lua (Novottf-200t) |
| Deciphera Pharmaceuticals INC. | $18.79 | 2025 | Romvimza, Qinlock |
| Agios Pharmaceuticals, INC. | $18.44 | 2025 | Pyrukynd |
| Janssen Pharmaceuticals, INC | $18.04 | 2024 | Xarelto |
| Tolmar, INC. | $18.02 | 2025 | Rubraca, Eligard |
| Pharmaand Gmbh | $18.02 | 2025 | Rubraca |
| Emd Serono, INC. | $17.91 | 2022 | |
| Jazz Pharmaceuticals INC. | $17.05 | 2025 | |
| Merck Sharp & Dohme LLC | $16.59 | 2024 | Keytruda, Lynparza |
| Celgene Corporation | $16.56 | 2025 | Reblozyl |
| Geron Corporation | $16.50 | 2025 | Rytelo |
| Array Biopharma INC | $16.21 | 2024 | Tukysa, Braftovi, Mektovi |
| Alexion Pharmaceuticals, INC. | $15.37 | 2025 | Ultomiris |
| Heron Therapeutics, INC. | $15.36 | 2022 | |
| Bausch & Lomb Americas INC. | $15.06 | 2024 | Doctors Allergy Formula |
| Genmab U.S., INC. | $14.86 | 2022 | |
| Amneal Pharmaceuticals LLC | $14.65 | 2025 | Alymsys |
| Servier Pharmaceuticals LLC | $14.38 | 2025 | |
| Cti Biopharma Corp. | $14.12 | 2023 | Vonjo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jihane Saade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.